Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 12.

Journal Article

D'Ambrosio, Lorenzo, Touati, Nathan, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Grignani, Giovanni, Flippot, Ronan, Czarnecka, Anna M., Piperno-Neumann, Sophie, Martin-Broto, Javier ORCID: 0000-0001-7350-6916, Sanfilippo, Roberta, Katz, Daniela, Duffaud, Florence, Vincenzi, Bruno, Stark, Daniel P., Mazzeo, Filomena, Tuchscherer, Armin, Chevreau, Christine, Sherriff, Jenny, Estival, Anna, Litiere, Saskia, Sents, Ward, Ray-Coquard, Isabelle, Tolomeo, Francesco, Le Cesne, Axel, Rutkowski, Piotr, Stacchiotti, Silvia, Kasper, Bernd, Gelderblom, Hans and Gronchi, Alessandro (2020). Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer, 126 (11). S. 2637 - 2648. HOBOKEN: WILEY. ISSN 1097-0142

Subbiah, Vivek ORCID: 0000-0002-6064-6837, Puzanov, Igor, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian ORCID: 0000-0003-0286-8703, Lockhart, A. Craig, Raje, Noopur S., Wolf, Juergen, Baselga, Jose, Meric-Bernstam, Funda, Roszik, Jason ORCID: 0000-0002-4561-6170, Diamond, Eli L., Riely, Gregory J., Sherman, Eric J., Riehl, Todd, Pitcher, Bethany and Hyman, David M. (2020). Pan-Cancer Efficacy of Vemurafenib in BRAF(V)(600)-Mutant Non-Melanoma Cancers. Cancer Discov., 10 (5). S. 657 - 664. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2159-8290

Kaley, Thomas, Touat, Mehdi, Subbiah, Vivek ORCID: 0000-0002-6064-6837, Hollebecque, Antoine, Rodon, Jordi, Lockhart, A. Craig, Keedy, Vicki, Bielle, Franck, Hofheinz, Ralf-Dieter, Joly, Florence, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian, Puzanov, Igor, Raje, Noopur S., Wolf, Jurgen, DeAngelis, Lisa M., Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany, Baselga, Jose and Hyman, David M. (2018). BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study. J. Clin. Oncol., 36 (35). S. 3477 - 3487. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Diamond, Eli L., Subbiah, Vivek ORCID: 0000-0002-6064-6837, Lockhart, A. Craig, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena ORCID: 0000-0002-4653-6324, Martinez-Valle, Ferran, Durham, Benjamin ORCID: 0000-0001-8090-5448, Arcila, Maria E., Ulaner, Gary, Abdel-Wahab, Omar, Pitcher, Bethany, Makrutzki, Martina, Riehl, Todd, Baselga, Jose and Hyman, David M. (2018). Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study. JAMA Oncol., 4 (3). S. 384 - 389. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Raje, Noopur, Chau, Ian, Hyman, David M., Ribrag, Vincent, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Tabernero, Josep, Elez, Elena, Wolf, Jurgen, Yee, Andrew J., Kaiser, Martin, Landau, Heather, Michot, Jean-Marie, Hollebecque, Antoine, Veronese, Luisa, Makrutzki, Martina, Pitcher, Bethany, Puzanov, Igor and Baselga, Jose (2018). Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-BASKET Study. JCO Precis. Oncol., 2. S. 1 - 10. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 2473-4284

Rusakiewicz, Sylvie, Perier, Aurelie, Semeraro, Michaela, Pitt, Jonathan M., von Strandmann, Elke Pogge, Reiners, Katrin S., Aspeslagh, Sandrine, Piperoglou, Christelle, Vely, Frederic, Ivagnes, Alexandre, Jegou, Sarah, Halama, Niels, Chaigneau, Loic, Validire, Pierre, Christidis, Christos, Perniceni, Thierry, Landi, Bruno, Berger, Anne, Isambert, Nicolas, Domont, Julien, Bonvalot, Sylvie, Terrier, Philippe, Adam, Julien, Coindre, Jean-Michel, Emile, Jean-Francois, Poirier-Colame, Vichnou, Chaba, Kariman, Rocha, Benedita, Caignard, Anne ORCID: 0000-0001-9923-6045, Toubert, Antoine, Enot, David, Koch, Joachim, Marabelle, Aurelien, Lambert, Marion, Caillat-Zucman, Sophie ORCID: 0000-0002-4535-3550, Leyvraz, Serge, Auclair, Christian, Vivier, Eric ORCID: 0000-0001-7022-8287, Eggermont, Alexander, Borg, Christophe, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Le Cesne, Axel, Mir, Olivier ORCID: 0000-0002-6761-4002 and Zitvogel, Laurence (2017). NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. OncoImmunology, 6 (1). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Hyman, David Michael, Kaley, Thomas Joseph, Hollebecque, Antoine ORCID: 0000-0003-2869-7551, Subbiah, Vivek ORCID: 0000-0002-6064-6837, Ahnert, Jordi Rodon, Lockhart, A. Craig, Keedy, Vicki Leigh, Hofheinz, Railf, Lobbedez, Florence Joly, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian, Puzanov, Igor, Raje, Noopur, Wolf, Juergen, Makrutzki, Martina, Riehl, Todd, Pitcher, Bethany and Baselga, Jose (2017). Vemurafenib in patients with BRAF(V600) mutant glioma: A cohort of the histology-independent VE-basket study. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Diamond, Eli L., Subbiah, Vivek ORCID: 0000-0002-6064-6837, Lockhart, Craig, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Faris, Jason E., Puzanov, Igor, Chau, Ian ORCID: 0000-0003-0286-8703, Raje, Noopur S., Wolf, Juergen S., Erinjeri, Joe, Torrisi, Jean, Ulaner, Gary, Lacouture, Mario, Robson, Susan, Makrutzki, Martina, Elez, Elena, Tabernero, Josep, Abdel-Wahab, Omar, Baselga, Jose and Hyman, David M. (2016). Vemurafenib in Patients with Erdheim-Chester Disease (ECD) and Langerhans Cell Histiocytosis (LCH) Harboring BRAF(V600) Mutations: A Cohort of the Histology-Independent VE-Basket Study. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Raje, Noopur, Chau, Ian ORCID: 0000-0003-0286-8703, Hyman, David M., Ribrag, Vincent, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Tabernero, Josep, Elena Elez-Fernandez, Maria, Wolf, Juergen S., Sirzen, Florin, Yee, Andrew, Faris, Jason, Kaiser, Martin, Landau, Heather, Michot, Jean-Marie, Veronese, Luisa, Makrutzki, Martina, Lasserre, Susan Francis, Puzanov, Igor and Baselga, Jose (2015). Vemurafenib (VEM) in Relapsed Refractory Multiple Myeloma Harboring BRAF(V600) Mutations (V600m): A Cohort of the Histology-Independent VE-Basket Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hyman, David M., Puzanov, Igor, Subbiah, Vivek ORCID: 0000-0002-6064-6837, Faris, Jason E., Chau, Ian ORCID: 0000-0003-0286-8703, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Wolf, Juergen, Raje, Noopur S., Diamond, Eli L., Hollebecque, Antoine ORCID: 0000-0003-2869-7551, Gervais, Radj, Elena Elez-Fernandez, Maria, Italiano, Antoine, Hofheinz, Ralf-Dieter, Hidalgo, Manuel, Chan, Emily, Schuler, Martin, Lasserre, Susan Frances, Makrutzki, Martina, Sirzen, Florin, Veronese, Maria Luisa, Tabernero, Josep ORCID: 0000-0002-2495-8139 and Baselga, Jose (2015). Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. N. Engl. J. Med., 373 (8). S. 726 - 737. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Tabernero, Josep, Chan, Emily, Baselga, Jose, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian ORCID: 0000-0003-0286-8703, Hyman, David Michael, Raje, Noopur S., Wolf, Juergen, Sirzen, Florin, Veronese, Maria Luisa, Mitchell, Lada and Hidalgo, Manuel (2014). VE-BASKET, a Simon 2-stage adaptive design, phase II, histology-independent study in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m): Activity of vemurafenib (VEM) with or without cetuximab (CTX) in. colorectal cancer (CRC). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hyman, David Michael, Blay, Jean-Yves ORCID: 0000-0001-7190-120X, Chau, Ian ORCID: 0000-0003-0286-8703, Raje, Noopur S., Fernandez, Maria Elena Elez, Wolf, Juergen, Sirzen, Florin, Veronese, Maria Luisa, Mitchell, Lada, Puzanov, Igor and Baselga, Jose (2014). VE-BASKET, a first-in-kind, phase II, histology-independent basket study of vemurafenib (VEM) in nonmelanoma solid tumors harboring BRAF V600 mutations (V600m). J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Fri Jan 28 08:46:04 2022 CET.